Compare the Ketofol and Sodium thiopental in General anesthesia patients undergoing dilatation and curettage

Compare the Ketofol and Sodium thiopental in General anesthesia patients undergoing dilatation and curettage in Alavi hospital from 2016

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017031923559N9

Enrollment

Registered

2017-04-24

Start date

2017-04-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgical abortion. Complete or unspecified, complicated by delayed or excessive haemorrhage

Interventions

The first group injected Ketofol that contains a half milligrams per kilogram of ketamine and 1 mg per kg body weight propofol before the surgery. The second group of three milligrams per kilogram of

Treatment - Drugs

The first group injected Ketofol that contains a half milligrams per kilogram of ketamine and 1 mg per kg body weight propofol before the surgery. The second group of three milligrams per kilogram o

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Vaginal bleeding; patients suspected to have an abortion; Patients candidate of uterine curettage; consent to participate in the study. Exclusion criteria: contraindication to uterine curettage; sensitivity to Ketofol and Sodium thiopental

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Apnea. Timepoint: Intraoperative. Method of measurement: Based on the patient's respiratory status.	—

Secondary

Measure	Time frame
Patient satisfaction of anesthesia. Timepoint: Intraoperative. Method of measurement: question of patient.;Decreased oxygen saturation. Timepoint: Intraoperative. Method of measurement: According to pulse oximetry.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahzad Yousefian

Ardabil University of Medical Sciences

mahzad_yousefian@yahoo.com+98 45 3225 1688

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026